Post job

Oncology Analytics CEO and executives

Executive Summary. Based on our data team's research, Rick Dean is the Oncology Analytics's CEO. Oncology Analytics has 138 employees, of which 24 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Oncology Analytics executive team is 21% female and 79% male.
  • 67% of the management team is White.
  • 9% of Oncology Analytics management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Oncology Analytics?
Share your experience

Rate Oncology Analytics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Rick Dean

Chief Executive Officer

Rick Dean's LinkedIn

Rick Dean is a Chief Executive Officer at Oncology Analytics Inc and is based in Atlanta, Georgia. He has worked as Senior Vice President, Optum Analytics at Optum; Co-Founder and General Partner at Optum Ventures; and Enterprise Sales Director at Jesper Borre. Rick works or has worked as VP:North American Sales at Sentillion. He attended University of North Carolina at Chapel Hill.

Marc Fishman

Founder

Marc Fishman's LinkedIn

Jennifer Haas

Chief Marketing Officer

Andrew Norden

Chief Medical Officer

Andrew Norden's LinkedIn

As Chief Medical Officer, Dr. Norden leads Oncology Analytics’ clinical team and strategy. An accomplished neuro-oncologist, Dr. Norden previously served as Chief Medical Officer of COTA, an oncology company focused on the curation and use of real-world data and evidence for cancer care and research. Before COTA, Dr. Norden served as Deputy Chief Health Officer and lead physician for oncology and genomics at IBM Watson Health. Before moving to IBM, Dr. Norden held several positions at the Dana-Farber Cancer Institute in Boston, including Associate Chief Medical Officer and Medical Director of Satellites and Network Affiliates. During his time at Dana Farber, Dr. Norden led clinical trials for patients with glioma, meningioma, and seizures in brain tumor patients. He is the author of more than 65 peer-reviewed papers. He is an active member of the American Society of Clinical Oncology and the Society for Neuro-Oncology, and he is an Associate Editor of JCO-Clinical Cancer Informatics. Dr. Norden attended medical school at Yale School of Medicine before moving to Boston for residency training at Massachusetts General and Brigham and Women’s Hospitals. After serving as Chief Resident, he completed a neuro-oncology fellowship at Dana-Farber. Dr. Norden also earned a Masters of Public Health degree from the Harvard University School of Public Health and an MBA from the University of Massachusetts, Amherst. He received his undergraduate degree in neuroscience from Brown University.

Anna Schorer

Board Member

Anna Schorer's LinkedIn

Dr. Schorer focuses on clinical informatics and data management capabilities supporting our commitment to the delivery of safe, high quality and cost effective care for cancer patients. Prior to joining Oncology Analytics, Dr. Schorer was a clinician, educator and researcher in hematology and medical oncology at the Minneapolis VA Health Care System for more than 2 decades. In this position, she was a nationally known innovator in the design and optimization of electronic health systems and clinical decision support. She conducted key healthcare improvement initiatives funded through the National Center for Patient Safety, the VA Office of Specialty Care Transformation, and the Midwest Health Care Network. Her project teams won awards for improving patient safety and care processes at the local, regional and national level. She also held a number of leadership roles within the Veterans Health Administration. Dr. Schorer received her MD degree and did her Internal Medicine Residency at the University of Minnesota. She completed a Hematology / Medical Oncology Fellowship at the University of Washington and the University of Minnesota. She is Board Certified in Hematology, Medical Oncology, and Clinical Informatics, in addition to holding a Certificate in Clinical Informatics from the American Medical Informatics Association.

Brian York

Chief Analytics Officer

Brian York's LinkedIn

Brian York is a Senior Vice President and Chief Analytics Officer at Oncology Analytics Inc and is based in Atlanta, Georgia. He has worked as Founder, Chief Executive Officer at RevenueMed; Partner at Accenture; and Founder, Chief Executive Officer at Fortius Health. Brian studied at Northwestern University between 1978 and 1982.

Christine Boyle

Chief Marketing Officer and SVP

Christine Boyle's LinkedIn

Christine Boyle is a Chief Marketing Officer and SVP at Oncology Analytics Inc and is based in Greater Boston Area. She has worked as Chief Marketing Officer and SVP at Inspirata (formerly Caradigm); Vice President, Commercial Operations at Inspirata (formerly Caradigm); and Vice President, Marketing at Sentillion. Christine attended Providence College.

David Fusari

Chief Technology Officer

David Fusari's LinkedIn

Successful healthcare technology entrepreneur with a focus on delivering technical solutions that solve real business problems and that create business value. Proven track record of co-founding and working with early stage companies leveraging contemporary technologies to develop systems that are deployable, scalable, and secure. Outstanding problem solver and innovator of new ideas and concepts. Excellent sales and customer interaction skills and experienced in balancing business needs with technical demands.

 CTO and co-founder of well-established venture backed global healthcare research network used

by top pharma and CROs

 CTO for a successful venture back startup acquired by Microsoft

 20+ years of healthcare domain experience and 15 years as a CTO

 19 issued patents

 Assembled great teams

Michael Weintraub

Board Member

Ashley Brevda

Corporate Counsel/Chief Compliance Officer

Ashley Brevda's LinkedIn

Ashley Brevda is a Corporate Counsel/Chief Compliance Officer at Oncology Analytics Inc and is based in Fort Lauderdale, Florida. She has worked as Associate Attorney at Michael P. Walsh, P.A.; Juvenile Department Intern at Office Of The State Attorney; and Associate Attorney at Cole, Scott & Kissane. Ashley works or has worked as Pro Bono Counsel at Legal Aid Society of Palm Beach County Inc. She studied at University of Florida Levin College of Law between 2007 and 2010 and University of Florida between 2004 and 2007.

Do you work at Oncology Analytics?

Does the leadership team provide a clear direction for Oncology Analytics?

Oncology Analytics jobs

Oncology Analytics founders

Name & TitleBio
Marc Fishman

Founder

Marc Fishman's LinkedIn

Oncology Analytics board members

Name & TitleBio
Anna Schorer

Board Member

Anna Schorer's LinkedIn

Dr. Schorer focuses on clinical informatics and data management capabilities supporting our commitment to the delivery of safe, high quality and cost effective care for cancer patients. Prior to joining Oncology Analytics, Dr. Schorer was a clinician, educator and researcher in hematology and medical oncology at the Minneapolis VA Health Care System for more than 2 decades. In this position, she was a nationally known innovator in the design and optimization of electronic health systems and clinical decision support. She conducted key healthcare improvement initiatives funded through the National Center for Patient Safety, the VA Office of Specialty Care Transformation, and the Midwest Health Care Network. Her project teams won awards for improving patient safety and care processes at the local, regional and national level. She also held a number of leadership roles within the Veterans Health Administration. Dr. Schorer received her MD degree and did her Internal Medicine Residency at the University of Minnesota. She completed a Hematology / Medical Oncology Fellowship at the University of Washington and the University of Minnesota. She is Board Certified in Hematology, Medical Oncology, and Clinical Informatics, in addition to holding a Certificate in Clinical Informatics from the American Medical Informatics Association.

Michael Weintraub

Board Member

Chaim Shustik

Board Member

David Cohn

Board Member

Graeme B. Bolger

Board Member

Graeme B. Bolger's LinkedIn

James Armitage

Board Member

Jordan Berlin

Board Member

Michael Baum

Board Member

Michael Liang

Board Member

Richard Wilder

Board Member

Richard Wilder's LinkedIn

Oncology Analytics leadership demographics

Oncology Analytics gender distribution in management team

  • The Oncology Analytics executive team is 21% female and 79% male.
  • Oncology Analytics is 29% female and 71% male company-wide.
Male
Male
79%
Company-wide: 71%
Female
Female
21%
Company-wide: 29%

Oncology Analytics executives by race

Management Team:
  • The most common ethnicity among Oncology Analytics executive officers is White.
  • 67% of the management team is White.
  • 10% of Oncology Analytics's management is Black or African American.
  • 9% of the management team is Hispanic or Latino.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 56% of employees are White.
  • 20% of employees are Hispanic or Latino.
  • 13% of employees are Black or African American.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Oncology Analytics jobs nearby

Oncology Analytics executives FAQs

Zippia gives an in-depth look into the details of Oncology Analytics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Oncology Analytics. The employee data is based on information from people who have self-reported their past or current employments at Oncology Analytics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Oncology Analytics. The data presented on this page does not represent the view of Oncology Analytics and its employees or that of Zippia.

Oncology Analytics may also be known as or be related to Oncology Analytics, Oncology Analytics Inc and Oncology Analytics, Inc.